title: A recent illustration of some essentials of circadian chronotherapy study design.
authors.forename: William
authors.initials: W
authors.lastname: Hrushesky
authors.forename: Patricia
authors.initials: P
authors.lastname: Wood
authors.forename: Francis
authors.initials: F
authors.lastname: Levi
authors.forename: Reinhard
authors.initials: R
authors.lastname: von Roemeling
authors.forename: Georg
authors.initials: G
authors.lastname: Bjarnason
authors.forename: Christian
authors.initials: C
authors.lastname: Focan
authors.forename: Klaus
authors.initials: K
authors.lastname: Meier
authors.forename: Germaine
authors.initials: G
authors.lastname: Cornélissen
authors.forename: Franz
authors.initials: F
authors.lastname: Halberg
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D019454:Chronotherapy / Q000379:methods*; D002945:Cisplatin / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D004317:Doxorubicin; D002945:Cisplatin